Outcomes of tafasitamab and lenalidomide in large B-cell lymphoma based on prior CD19-directed CAR T exposure

Mwanasha H. Merrill; Robert A. Redd; Nicholas Lambert; Paolo F. Caimi; Priyanka Pullarkat; Richard C. Godby; David A. Bond; Graham T. Wehmeyer; Jason Romancik; Behzad Amoozgar; Lori Leslie; Loretta J. Nastoupil; Jennifer L. Crombie; Jeremy S. Abramson; Arushi Khurana; Grzegorz S. Nowakowski; Kami Maddocks; Sarah C. Rutherford; Brad Kahl; Michelle Okwali; Michael J. Buege; Connie L. Batlevi; Philippe Armand; Gilles Salles; David A. Qualls

doi:10.1002/hem3.70253

Outcomes of tafasitamab and lenalidomide in large B-cell lymphoma based on prior CD19-directed CAR T exposure

Mwanasha H. Merrill
, Robert A. Redd
, Nicholas Lambert
, Paolo F. Caimi
, Priyanka Pullarkat
, Richard C. Godby
, David A. Bond
, Graham T. Wehmeyer
, Jason Romancik
, Behzad Amoozgar
, Lori Leslie
, Loretta J. Nastoupil
, Jennifer L. Crombie
, Jeremy S. Abramson
, Arushi Khurana
, Grzegorz S. Nowakowski
, Kami Maddocks
, Sarah C. Rutherford
, Brad Kahl
, Michelle Okwali

Michael J. Buege, Connie L. Batlevi, Philippe Armand, Gilles Salles, David A. Qualls

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English
Article number	e70253
Journal	HemaSphere
Volume	9
Issue number	11
DOIs	https://doi.org/10.1002/hem3.70253
State	Published - Nov 2025

Access to Document

10.1002/hem3.70253

Cite this

Merrill, M. H., Redd, R. A., Lambert, N., Caimi, P. F., Pullarkat, P., Godby, R. C., Bond, D. A., Wehmeyer, G. T., Romancik, J., Amoozgar, B., Leslie, L., Nastoupil, L. J., Crombie, J. L., Abramson, J. S., Khurana, A., Nowakowski, G. S., Maddocks, K., Rutherford, S. C., Kahl, B., ... Qualls, D. A. (2025). Outcomes of tafasitamab and lenalidomide in large B-cell lymphoma based on prior CD19-directed CAR T exposure. HemaSphere, 9(11), Article e70253. https://doi.org/10.1002/hem3.70253

@article{733cace22fdd462c96dbd6f46c55f698,

title = "Outcomes of tafasitamab and lenalidomide in large B-cell lymphoma based on prior CD19-directed CAR T exposure",

author = "Merrill, \{Mwanasha H.\} and Redd, \{Robert A.\} and Nicholas Lambert and Caimi, \{Paolo F.\} and Priyanka Pullarkat and Godby, \{Richard C.\} and Bond, \{David A.\} and Wehmeyer, \{Graham T.\} and Jason Romancik and Behzad Amoozgar and Lori Leslie and Nastoupil, \{Loretta J.\} and Crombie, \{Jennifer L.\} and Abramson, \{Jeremy S.\} and Arushi Khurana and Nowakowski, \{Grzegorz S.\} and Kami Maddocks and Rutherford, \{Sarah C.\} and Brad Kahl and Michelle Okwali and Buege, \{Michael J.\} and Batlevi, \{Connie L.\} and Philippe Armand and Gilles Salles and Qualls, \{David A.\}",

year = "2025",

month = nov,

doi = "10.1002/hem3.70253",

language = "English",

volume = "9",

journal = "HemaSphere",

issn = "2572-9241",

number = "11",

}

Merrill, MH, Redd, RA, Lambert, N, Caimi, PF, Pullarkat, P, Godby, RC, Bond, DA, Wehmeyer, GT, Romancik, J, Amoozgar, B, Leslie, L, Nastoupil, LJ, Crombie, JL, Abramson, JS, Khurana, A, Nowakowski, GS, Maddocks, K, Rutherford, SC, Kahl, B, Okwali, M, Buege, MJ, Batlevi, CL, Armand, P, Salles, G & Qualls, DA 2025, 'Outcomes of tafasitamab and lenalidomide in large B-cell lymphoma based on prior CD19-directed CAR T exposure', HemaSphere, vol. 9, no. 11, e70253. https://doi.org/10.1002/hem3.70253

TY - JOUR

T1 - Outcomes of tafasitamab and lenalidomide in large B-cell lymphoma based on prior CD19-directed CAR T exposure

AU - Merrill, Mwanasha H.

AU - Redd, Robert A.

AU - Lambert, Nicholas

AU - Caimi, Paolo F.

AU - Pullarkat, Priyanka

AU - Godby, Richard C.

AU - Bond, David A.

AU - Wehmeyer, Graham T.

AU - Romancik, Jason

AU - Amoozgar, Behzad

AU - Leslie, Lori

AU - Nastoupil, Loretta J.

AU - Crombie, Jennifer L.

AU - Abramson, Jeremy S.

AU - Khurana, Arushi

AU - Nowakowski, Grzegorz S.

AU - Maddocks, Kami

AU - Rutherford, Sarah C.

AU - Kahl, Brad

AU - Okwali, Michelle

AU - Buege, Michael J.

AU - Batlevi, Connie L.

AU - Armand, Philippe

AU - Salles, Gilles

AU - Qualls, David A.

PY - 2025/11

Y1 - 2025/11

UR - https://www.scopus.com/pages/publications/105022486642

U2 - 10.1002/hem3.70253

DO - 10.1002/hem3.70253

M3 - Letter

AN - SCOPUS:105022486642

SN - 2572-9241

VL - 9

JO - HemaSphere

JF - HemaSphere

IS - 11

M1 - e70253

ER -

Outcomes of tafasitamab and lenalidomide in large B-cell lymphoma based on prior CD19-directed CAR T exposure

Access to Document

Other files and links

Cite this